Furthermore, simultaneous inhibition of kinases and NHE1 synergistically reduced intracellular pH and suppressed AML growth, whereas combining kinase inhibitors, such as quizartinib or ibrutinib, with amiloride enhanced intracellular acidification and cytotoxicity. This evidence concerns the gene SLC9A1 and acute myeloid leukemia.